La révolution des anticorps monoclonaux dans la prise en charge des microangiopathies thrombotiques [The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy]. Sauvètre G, Grange S, Froissart A, Veyradier A, Coppo P, Benhamou Y.Rev Med Interne. 2015 May;36(5):328-38.

Purpura thrombotique thrombocytopénique et autres syndromes de microangiopathie thrombotique au cours de l’infection par le virus de l’immunodéficience humaine. Gilardin L, Malak S, Schoindre Y, Galicier L, Veyradier A, Coppo P. Rev Med Interne. 2012 Jan 24. PubMed PMID: 22280852.

ADAMTS13, la protéase spécifique du clivage du facteur von Willebrand. Veyradier A, Coppo P. Med Sci (Paris). 2011 Dec;27(12):1097-105.

Le syndrome hémolytique et urémique atypique: où en est-on en 2011 ? Chantal Loirat, Fadi Fakhouri, Arnaud Garnier, Frank Bienaimé, Anne-Laure Sellier-Leclerc, Véronique Frémeaux-Bacchi.

Purpura thrombotique thrombocytopénique par déficit héréditaire en ADAMTS13 (syndrome d’Upshaw-Schulman) : actualités et perspectives. Veyradier A, Loirat C, Girma JP, Ribba AS, Wolf M, Coppo P, Meyer D. Hématologie 2005 ; 11 (5) : 321-34

Rituximab in autoimmune thrombotic thrombocytopenic purpura: A success story. Froissart A, Veyradier A, Hié M, Benhamou Y, Coppo P; French Reference Center for Thrombotic Microangiopathies. Eur J Intern Med. 2015 Nov;26(9):659-65.

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura. Roriz M, Landais M, Desprez J, Barbet C, Azoulay E, Galicier L, Wynckel A, Baudel JL, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Delmas Y, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Chauveau D, Veyradier A, Halimi JM, Hamidou M,Coppo P; French Thrombotic Microangiopathies Reference Center. Medicine (Baltimore). 2015 Oct;94(42):e1598.

Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study. Toussaint-Hacquard M, Coppo P, Soudant M, Chevreux L, Mathieu-Nafissi S, Lecompte T, Gross S, Guillemin F, Schneider T. Transfusion. 2015 Oct;55(10):2445-51.

Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC. de Fontbrune FS, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S, Bay JO, Neven B, Moussi J, Simon L, Xhaard A, Resche-Riggon M, O'Meara A, Fremeaux-Bacchi V, Veyradier A, Socié G, Coppo P, de Latour RP. Transplantation. 2015 Sep;99(9):1953-9.

Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease. Delmas Y, Helou S, Chabanier P, Ryman A, Pelluard F, Carles D, Boisseau P, Veyradier A, Horovitz J, Coppo P, Combe C. BMC Pregnancy Childbirth. 2015 Jun 17;15:137.

Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center. Benhamou Y, Baudel JL, Wynckel A, Galicier L, Azoulay E, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Halimi JM, Rivière E, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Hamidou M, Chauveau D, Veyradier A, Coppo P. Am J Hematol. 2015 Jun;90(6):E127-9.

Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center. Benhamou Y, Boelle PY, Baudin B, Ederhy S, Gras J, Galicier L, Azoulay E, Provôt F, Maury E, Pène F, Mira JP, Wynckel A, Presne C, Poullin P, Halimi JM, Delmas Y, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Hamidou M, Cohen A, Veyradier A, Coppo P; Reference Center for Thrombotic Microangiopathies. J Thromb Haemost. 2015 Feb;13(2):293-302.

Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement. Joly B, Stepanian A, Hajage D, Thouzeau S, Capdenat S, Coppo P, Veyradier A. Thromb Res. 2014 Nov;134(5):1074-80.

Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study. Widemann A, Pasero C, Arnaud L, Poullin P, Loundou AD, Choukroun G, Sanderson F, Lacroix R, Sabatier F, Coppo P, Dignat-George F, Kaplanski G; ENDO-13 study group. J Thromb Haemost. 2014 Oct;12(10):1601-9.

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura. Hie M, Gay J, Galicier L, Provôt F, Presne C, Poullin P, Bonmarchand G, Wynckel A, Benhamou Y, Vanhille P, Servais A, Bordessoule D, Coindre JP, Hamidou M, Vernant JP, Veyradier A, Coppo P; French Thrombotic Microangiopathies Reference Centre. Blood. 2014 Jul 10;124(2):204-10.

High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center. Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, Fortier C, London J, Bonmarchand G, Wynckel A, Provôt F, Poullin P, Vanhille P, Presne C, Bordessoule D, Girault S, Delmas Y, Hamidou M, Mousson C, Vigneau C, Lautrette A, Pourrat J, Galicier L, Azoulay E, Pène F, Mira JP, Rondeau E, Ojeda-Uribe M, Charron D, Maury E, Guidet B, Veyradier A, Tamouza R, Coppo P; Thrombotic Microangiopathies Reference Center. Transfusion. 2014 Feb;54(2):389-97.

Bilateral serous detachment of retina: an unusual mode of revelation of thrombotic thrombocytopenic purpura of favorable outcome with plasma exchange. Titah C, Abisror N, Buffet M, Coppo P. Graefes Arch Clin Exp Ophthalmol. 2014 Jan;252(1):181-3.

Evaluation of a commercial assay for ADAMTS13 activity measurement. Thouzeau S, Capdenat S, Stépanian A, Coppo P, Veyradier A. Thromb Haemost. 2013 Oct;110(4):852-3.

Response to “Predictors of survival in thrombotic thrombocytopenic purpura” Haematologica 2013;98(5):e58. Coppo P. Haematologica. 2013 Jul;98(7):e80.

Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy. Peffault de Latour R, Xhaard A, Fremeaux-Bacchi V, Coppo P, Fischer AM, Helley D, Socié G. Br J Haematol. 2013 Apr;161(2):279-80.

Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience. Benhamou Y, Assié C, Boelle PY, Buffet M, Grillberger R, Malot S, Wynckel A, Presne C, Choukroun G, Poullin P, Provôt F, Gruson D, Hamidou M, Bordessoule D, Pourrat J, Mira JP, Le Guern V, Pouteil-Noble C, Daubin C, Vanhille P, Rondeau E, Palcoux JB, Mousson C, Vigneau C, Bonmarchand G, Guidet B, Galicier L, Azoulay E, Rottensteiner H, Veyradier A, Coppo P; Thrombotic Microangiopathies Reference Center. Haematologica. 2012 Aug;97(8):1181-6

Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura. Moatti-Cohen M, Garrec C, Wolf M, Boisseau P, Galicier L, Azoulay E, Stepanian A, Delmas Y, Rondeau E, Bezieau S, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Blood. 2012 Jun 14;119(24):5888-97.

Thrombotic microangiopathies: from empiricism to targeted therapies. Coppo P. Presse Med. 2012 Mar;41(3 Pt 2):e101-4.

Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura. Coppo P, Veyradier A. Presse Med. 2012 Mar;41(3 Pt 2):e163-76.

Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience. Beloncle F, Buffet M, Coindre JP, Munoz-Bongrand N, Malot S, Pène F, Mira JP, Galicier L, Guidet B, Baudel JL, Subra JF, Tanguy-Schmidt A, Pourrat J, Azoulay E, Veyradier A, Coppo P. Transfusion. 2012 Mar 8. PubMed PMID: 22404639.

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center. Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P. Crit Care Med. 2012 Jan;40(1):104-111.

Atypical hemolytic uremic syndrome. Loirat C, Frémeaux-Bacchi V. Orphanet J Rare Dis. 2011 Sep 8;6:60.

Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C, Poullin P, Malot S, Vanhille P, Azoulay E, Galicier L, Lemiale V, Mira JP, Ridel C, Rondeau E, Pourrat J, Girault S, Bordessoule D, Saheb S, Ramakers M, Hamidou M, Vernant JP, Guidet B, Wolf M, Veyradier A; French Reference Center for Thrombotic Microangiopathies. PLoS One. 2010 Apr 23;5(4).

HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians. Coppo P, Busson M, Veyradier A, Wynckel A, Poullin P, Azoulay E, Galicier L, Loiseau P; French Reference Centre For Thrombotic Microangiopathies. J Thromb Haemost. 2010 Apr;8(4):856-9.

Cancer awareness in atypical thrombotic microangiopathies. Oberic L, Buffet M, Schwarzinger M, Veyradier A, Clabault K, Malot S, Schleinitz N, Valla D, Galicier L, Bengrine-Lefèvre L, Gorin NC, Coppo P; Reference Center for the Management of Thrombotic Microangiopathies. Oncologist. 2009 Aug;14(8):769-79.

Thrombotic microangiopathies: towards a pathophysiology-based classification. Coppo P, Veyradier A. Cardiovasc Hematol Disord Drug Targets. 2009 Mar;9(1):36-50. Revue.

Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity. Malak S, Wolf M, Millot GA, Mariotte E, Veyradier A, Meynard JL, Korach JM, Malot S, Bussel A, Azoulay E, Boulanger E, Galicier L, Devaux E, Eschwège V, Gallien S, Adrie C, Schlemmer B, Rondeau E, Coppo P; Réseau d’Étude des Microangiopathies Thrombotiques (TMA-Rare Diseases Reference Center). Scand J Immunol. 2008 Sep;68(3):337-44.

Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity. Ferrari S, Scheiflinger F, Rieger M, Mudde G, Wolf M, Coppo P, Girma JP, Azoulay E, Brun-Buisson C, Fakhouri F, Mira JP, Oksenhendler E, Poullin P, Rondeau E, Schleinitz N, Schlemmer B, Teboul JL, Vanhille P, Vernant JP, Meyer D, Veyradier A; French Clinical and Biological Network on Adult Thrombotic Microangiopathies. Blood. 2007 Apr 1;109(7):2815-22.

Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura. Coppo P, Wolf M, Veyradier A, Bussel A, Malot S, Millot GA, Daubin C, Bordessoule D, Pène F, Mira JP, Heshmati F, Maury E, Guidet B, Boulanger E, Galicier L, Parquet N, Vernant JP, Rondeau E, Azoulay E, Schlemmer B; Réseau d'Etude des Microangiopathies Thrombotiques de l'Adulte. Br J Haematol. 2006 Jan;132(1):66-74. Revue.

Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Coppo P, Bengoufa D, Veyradier A, Wolf M, Bussel A, Millot GA, Malot S, Heshmati F, Mira JP, Boulanger E, Galicier L, Durey-Dragon MA, Frémeaux-Bacchi V, Ramakers M, Pruna A, Bordessoule D, Gouilleux V, Scrobohaci ML, Vernant JP, Moreau D, Azoulay E, Schlemmer B, Guillevin L, Lassoued K; Réseau d'Etude des Microangiopathies Thrombotiques de l'Adulte. Medicine (Baltimore). 2004 Jul;83(4):233-44.

Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients ? Coppo P, Adrie C, Azoulay E, Leleu G, Oksenhendler E, Galicier L, Le Gall JR, Bussel A, Schlemmer B. Intensive Care Med. 2003 Apr;29(4):564-9.